Small cell lung cancer (SCLC) studies reveal its cooperation with OCT4 to activate Myc [101], and in pancreatic cancer, it modulates survival through the PI3K/Akt/mTOR pathway [46,110]. This evidence concerns the gene MTOR and small cell lung carcinoma.